Form 8K CURALEAF HOLDINGS For: 12 August
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Curaleaf Holdings Inc (CURA)
Curaleaf Holdings Inc stock price live, this page displays TSX CURA stock exchange data. View the CURA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Curaleaf Holdings Inc real time stock price chart below.
What Is the Curaleaf Holdings Inc Stock Price Today?
The Curaleaf Holdings Inc stock price today is 13.80.
What Is the Stock Symbol for Curaleaf Holdings Inc?
The stock symbol for Curaleaf Holdings Inc is "CURA."
What Stock Exchange Does Curaleaf Holdings Inc Trade On?
Curaleaf Holdings Inc is listed and trades on the Toronto stock exchange.
Is Curaleaf Holdings Inc a Good Stock to Buy?
Determining whether Curaleaf Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CURA quote. (ISIN: CA23126M3003)
What Is the Curaleaf Holdings Inc Stock Price Today?
The Curaleaf Holdings Inc stock price today is 13.80.
What Is the Stock Symbol for Curaleaf Holdings Inc?
The stock symbol for Curaleaf Holdings Inc is "CURA."
What Stock Exchange Does Curaleaf Holdings Inc Trade On?
Curaleaf Holdings Inc is listed and trades on the Toronto stock exchange.
Is Curaleaf Holdings Inc a Good Stock to Buy?
Determining whether Curaleaf Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CURA quote. (ISIN: CA23126M3003)
13.80
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.51
13.95
52 wk Range
7.77
20.93
CURA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.5113.95
52 wk Range
7.7720.93
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CURA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
18.55
Upside
+34.42%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Curaleaf receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Form 8K CURALEAF HOLDINGS For: 12 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 18.55
(+34.42% Upside)
Curaleaf Holdings Inc Earnings Call Summary for Q2/2026
- Q2 revenue rose 10% YoY to $340M with net income of $12.5M ($0.05/share) vs. $48M loss prior year; shares fell 7.4% to $11.71.
- Gross margin improved to 50%, up 170bps YoY; adjusted EBITDA reached $70M (21% margin) despite international operations drag.
- Q3 revenue guidance of ~$347M (low single-digit sequential growth) disappointed investors; company targets $35M-$40M SG&A cuts over 12 months.
- Management declared shift from 'stabilization to acceleration' phase, citing Schedule III reclassification as defining policy moment for cannabis.
- International expansion prioritized with plan to increase internal supply sourcing from 20% to 50-75% within 6-12 months; uplisting preparation underway.
Last Updated: 08/06/2026, 06:14 AM
Read Full TranscriptEarnings
Latest Release
Aug 06, 2026
EPS / Forecast
0.05 / -0.06
Revenue / Forecast
340.1M / 332.24M
Compare CURA to Peers and Sector
Metrics to compare | CURA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCURAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −63.6x | −2.5x | −0.3x | |
PEG Ratio | −0.78 | 0.01 | 0.00 | |
Price/Book | 3.0x | 0.6x | 2.6x | |
Price / LTM Sales | 2.0x | 1.3x | 3.1x | |
Upside (Analyst Target) | 34.5% | 138.2% | 48.3% | |
Fair Value Upside | Unlock | 16.7% | 6.7% | Unlock |
Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Curaleaf (CURA) Stock Price Today?
The Curaleaf stock price today is 13.80 CAD.
What Stock Exchange Does Curaleaf Trade On?
Curaleaf is listed and trades on the Toronto Stock Exchange.
What Is the Stock Symbol for Curaleaf?
The stock symbol for Curaleaf is "CURA."
What Is the Curaleaf Market Cap?
As of today, Curaleaf market cap is 3.65B CAD.
What Is Curaleaf's Earnings Per Share (TTM)?
The Curaleaf EPS (TTM) is -0.16.
When Is the Next Curaleaf Earnings Date?
Curaleaf will release its next earnings report on Aug 12, 2026.
From a Technical Analysis Perspective, Is CURA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Curaleaf Stock Split?
Curaleaf has split 3 times.
How Many Employees Does Curaleaf Have?
Curaleaf has 5554 employees.
What is the current trading status of Curaleaf (CURA)?
As of Aug 13, 2026, Curaleaf (CURA) is trading at a price of 13.80 CAD, with a previous close of 13.80 CAD. The stock has fluctuated within a day range of 13.51 CAD to 13.95 CAD, while its 52-week range spans from 7.77 CAD to 20.93 CAD.
What Is Curaleaf (CURA) Price Target According to Analysts?
The average 12-month price target for Curaleaf is 18.55 CAD, with a high estimate of 21.02359513 CAD and a low estimate of 16.0183757 CAD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +34.42% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.